Humira retained the top spot on the list of the top 20 selling drugs in 2020. The AbbVie Inc.(NYSE:ABBV) mega-blockbuster generated revenue of nearly $20.4 billion last year, according to an article ...
Sales of AbbVie’s blockbuster drug Humira peaked at $18.9bn last year and, according to analysts at Evaluate Pharma, the product is expected to generate $15.2bn through to 2024. These figures are ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The first Humira biosimilar hit the U.S. market a little ...
No more waiting: Humira’s judgment day has finally arrived. The first Humira biosimilar, Amgen’s Amjevita, is set to reach the market Tuesday and kick off a tsunami-sized wave of competition. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results